How to “live well” with prostate cancer

There’s no simple way to prevent the onset of prostate cancer or to prevent its progression over time (e.g., based on diet or taking supplements or exercising like a maniac). However, … READ MORE …

FamGenix — a family health history app

As the Democratic Party discovered this week in Iowa, apps can have problems. However, there are also apps that prove to be very useful straight out of the gate — and they can be improved over time too. … READ MORE …

Participation in a patient support group increases prostate cancer patient knowledge

A newly published study from a group of German researchers examined the degree to which participation in patient support group activities increased prostate cancer patients’ health literacy and, specifically, their prostate cancer‐specific and non‐cancer‐specific knowledge about health care. … READ MORE …

New test now available for identification of AR-V7 mutations in mCRPC

According to a media release issued yesterday, Genomic Health has now made available a commercial test for risk of the AR-V7 mutation in men with metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …

Research survey on male sexuality and prostate cancer

A team of researchers at the University of Calgary in Canada is seeking men with a history of prostate cancer willing to complete a survey related to men’s sexuality. … READ MORE …

Second CureTalk discussion on living well with prostate cancer

This evening at 6:00 pm Eastern time we shall be continuing our conversation with Dr. Paul Schellhammer regarding ways to encourage patients to be able to “live well” after a diagnosis of prostate cancer. Click here to get the detailed information and join the discussion. … READ MORE …

Can phi density accurately predict risk for clinically significant prostate cancer?

A new article in BJU International has suggested the possibility that Prostate Health Index density (i.e., a patient’s phi score divided by his prostate volume) may be able to predict the probability of a finding of clinically significant prostate cancer on biopsy. … READ MORE …